In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Faculty:
Peter K. Kaiser, MD
Department of Ophthalmology
Cleveland Clinic
Cleveland, OH
Consulting Fees: Aerie, Alcon, Allegro, Allergan, Alzheon, Annexon Biosciences, AsclepiX, Bayer, Bausch + Lomb, Biogen Idec, Bionic Vision Technologies, Boehringer Ingelheim, Carl Zeiss Meditec, Clearside Biomedical, DTx Pharma, Duet Therapeutics, Eyevensys, Galecto Biotech, Galimedix, Gemini Therapeutics, Glaukos, Innovent, iRenix, Iveric Bio, jCyte, Kanaph Therapeutics, Kanghong, Kodiak, LensGen, NGM Biopharmaceuticals, Inc., Novartis, Ocugenix, Oculis, Ocuphire, OcuTerra Therapeutics Inc., Omeros, Opthea, Oxurion, Palatin, Regeneron, REGENXBIO, Retinal Sciences, Retrope, Roivant, Samsung Bioepis, Sandoz, Santen, Stealth BioTherapeutics, Sustained Nano Systems, Takeda, Théa
Reviewers/Content Planners/Authors:
- Emily Chew, MD has nothing to disclose.
- Cindy Davidson has nothing to disclose.
- Ann Early has nothing to disclose.
- Amanda Hilferty has nothing to disclose.
- Robert Schneider, MSW has nothing to disclose.
- Stephanie Wenick, MPhil has nothing to disclose.
Facebook Comments